Market Overview

Benzinga's Top Upgrades

Related TEVA
UPDATE: Teva Announces FDA Acceptance of NDA For Inhaler
4 Top Performing Health Care Stocks With More Upside Potential
Sofinnova Ventures Closes $500M Fund (Fox Business)
Related JASO
Canadian Solar's Unit Signs Largest Canadian EPC Contract - Analyst Blog
JA Solar Poised To Gain From Buoyant Solar Market In China - Analyst Blog

Analysts at Morgan Stanley upgraded Teva Pharmaceutical Industries (NYSE: TEVA) from “underweight” to “equal-weight.” The price target for Teva Pharmaceutical is set to $52. Teva Pharmaceutical's shares closed at $47.96 yesterday.

Axiom upgraded JA Solar Holdings Co (NASDAQ: JASO) from “undefined” to “buy.” The price target for JA Solar is set to $16. JA Solar's shares closed at $10.55 yesterday.

Analysts at Keefe Bruyette & Woods upgraded Independent Bank (NASDAQ: INDB) from “market perform” to “outperform.” The price target for Independent Bank has been raised from $40 to $44. Independent Bank's shares closed at $38.11 yesterday.

Oppenheimer upgraded Lowe's Companies (NYSE: LOW) from “market perform” to “outperform.” The price target for Lowe's Companies has been raised from $50 to $57. Lowe's shares closed at $48.71 yesterday.

Posted-In: top upgradesUpgrades Analyst Ratings

 

Most Popular

Related Articles (INDB + JASO)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free